ONCT-534 Earns FDA Fast Track Designa... - Advanced Prostate...

Advanced Prostate Cancer

21,854 members27,376 posts

ONCT-534 Earns FDA Fast Track Designation in R/R Metastatic CRPC

Maxone73 profile image
5 Replies

ONCT-534 recruiting

cancernetwork.com/view/onct...

Written by
Maxone73 profile image
Maxone73
To view profiles and participate in discussions please or .
5 Replies
kainasar profile image
kainasar

Thanks. Their is still hope.

Scout4answers profile image
Scout4answers

According to findings from preclinical studies, the agent has demonstrated activity in prostate cancer models with and without AR mutations.

Does not say what the basis for fast track is. Could it be more than mouse models?

Maxone73 profile image
Maxone73 in reply to Scout4answers

it's for investigational drugs development, I thought it would happen after an incredibly promising start of phase 1, but it seems that the potential and the fact that it would be a lifesaver can be enough

from what I read they will sun a phase 1/2 instead of two separate phases

Maxone73 profile image
Maxone73 in reply to Scout4answers

ah here you go: onclive.com/view/fda-allows...

they were already in phase 1/2 in august

j-o-h-n profile image
j-o-h-n

Good Luck, Good Health and Good Humor.

j-o-h-n Monday 10/30/2023 7:45 PM DST

My work of art............Little bastards having fun with my body.

Not what you're looking for?

You may also like...

FDA Fast Track Designation for 225Ac-FL-020 for mCRPCa

Another weapon, from Germany this time....ahhhh zee germanz! Actinium strikes again! Phase 1 trial...

FDA Grants Fast Track Designation for 177Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Is this superior to the LU177 now available?...

Syncromune Granted FDA Fast-Track Designation for SYNC-T SV-102 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

FORT LAUDERDALE, Fla., July 01, 2024 (GLOBE NEWSWIRE) -- Syncromune® Inc., a clinical-stage...

Olaparib Combo Improves PFS/Responses in Metastatic CRPC - from ASCO GU2024

I am not sure, they always mix BTCA 1/2 and ATM, but maybe I can find the data for ATM only...but...

Help with choosing treatment pathway

Would really appreciate feedback from members as to the Pros and Cons of recommended treatment...